AI Issuer Brief
ClaudeLoading cached brief…
Price change · trailing returns
Live · FMP| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.04% | -5.40% | +1.78% | -11.41% | -20.92% | -20.37% | -16.80% | +3.22% | +5.18% | +288.16% | +7522.53% |
Aftermarket
Live · FMPLast trade
$138.65
49 sh
Bid
$138.20
49 sh
Ask
$150.34
100 sh
Spread
$12.140
Fair value
Football field →Weighted blend
$286.22
+106.31% vs spot
Recommendation
Strong Buy
15 of 16 methods
Method spread
8bull6bear
±5% threshold
Analyst PT consensus: $194.80 (+40.42%)
Total assets
$6.62B
Total debt
$1.37B
Cash & equiv
$184.42M
Operating CF
$867.7M
Free cash flow
$856.69M
Buybacks
-$300M
Analyst view
DB · price_targets + analyst_gradesConsensus target
$194.80
+40.42% upside
Low
$180.00
Median
$195.00
High
$210.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- PTC for Startups Program Helps Companies Design, Produce, and Launch Next-Generation Productsprnewswire.com·May 13, 2026
- PTC Onshape Introduces Direct Altium Integration to Streamline ECAD-MCAD Collaborationprnewswire.com·May 12, 2026
- PTC Onshape Introduces Direct Altium Integration to Streamline ECAD-MCAD Collaborationprnewswire.com·May 12, 2026
- PTC Therapeutics Q1 Earnings Call Highlightsmarketbeat.com·May 08, 2026
- PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Resultsprnewswire.com·May 07, 2026
- PTC ANNOUNCES SECOND FISCAL QUARTER 2026 RESULTSprnewswire.com·May 06, 2026
- PTC's Windchill PLM designated by U.S. Army as its Official Enterprise Product Data Management (ePDM) Solutionprnewswire.com·May 06, 2026
- PTC Therapeutics to Participate in Upcoming Investor Conferencesprnewswire.com·May 04, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Dec 2025 | $685.83M | $166.52M | $1.39 |
| Q4 Sep 2025 | $893.8M | $347.79M | $2.94 |
| Q3 Jun 2025 | $643.94M | $141.33M | $1.17 |
| Q2 Mar 2025 | $636.37M | $162.64M | $1.35 |
| Q1 Dec 2024 | $565.13M | $82.23M | $0.68 |
| Q4 Sep 2024 | $626.55M | $126.52M | $1.04 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Lathan Corinna director | Sell | 675 | $106.14K | Mar 16, 2026 |
VON STAATS AARON C officer: EVP, Chief Legal Officer | Sell | 2,639 | $422.24K | Mar 03, 2026 |
VON STAATS AARON C officer: EVP, Chief Legal Officer | Sell | 232 | $37.37K | Feb 11, 2026 |
VON STAATS AARON C officer: EVP, Chief Legal Officer | Sell | 8 | $1.3K | Feb 11, 2026 |
Talvitie Kristian officer: EVP, Chief Financial Officer | Sell | 40,061 | $6.93M | Dec 09, 2025 |
Talvitie Kristian officer: EVP, Chief Financial Officer | Sell | 10,230 | $1.78M | Dec 09, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $2.74B | $982.39M | $734M | $6.08 | +26.80% |
| FY 2024 | $2.3B | $588.06M | $376.33M | $3.12 | +16.37% |
| FY 2023 | $2.1B | $458.47M | $245.54M | $2.06 | +11.71% |
| FY 2022 | $1.93B | $447.36M | $313.08M | $2.65 | +16.19% |
| FY 2021 | $1.81B | $380.75M | $476.92M | $4.03 | +26.39% |